Healthcare · Pharmaceuticals & Biotechnology
QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #72 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 18 Feb 2026 | Castilia Life Sciences LLP | Promoter group | Buy | 0 | ₹0 |
| 5 Dec 2025 | Castilia Life Sciences Private Limited | Promoter group | Buy | 0 | ₹0 |
| 5 Dec 2025 | Shri Rameshwara Investment Private Limited (RIPL) | Promoter group | Sell | 0 | ₹0 |
| 5 Dec 2025 | Shri Badrinath Investment Private Limited (RIPL) | Promoter group | Sell | 0 | ₹0 |
| 29 Dec 2022 | Ashok Vishwanath Hiremath | Promoter group | Buy | 0 | ₹0 |
| 29 Dec 2022 | Ashok Vishwanath Hiremath | Promoter group | Buy | 0 | ₹0 |
| 29 Dec 2022 | Ashok Vishwanath Hiremath | Promoter group | Buy | 0 | ₹0 |
| 26 Dec 2022 | Ashok Vishwanath Hiremath | Promoter group | Buy | 0 | ₹0 |
| 26 Dec 2022 | Ashok Vishwanath Hiremath | Promoter group | Buy | 0 | ₹0 |
| 26 Dec 2022 | Ashok Vishwanath Hiremath | Promoter group | Buy | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 7 Sep 2026 | QE SECURITIES LLP | Bulk | Sell | 1,089,461 | 244.5600 | NSE |
| 7 Sep 2026 | QE SECURITIES LLP | Bulk | Buy | 1,079,302 | 244.7400 | NSE |
| 7 Sep 2026 | NK SECURITIES RESEARCH PRIVATE LIMITED | Bulk | Buy | 1,000,807 | 245.4700 | NSE |
| 7 Sep 2026 | NK SECURITIES RESEARCH PRIVATE LIMITED | Bulk | Sell | 1,000,807 | 245.6000 | NSE |
| 7 Sep 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | Sell | 1,905,095 | 246.0600 | NSE |
| 7 Sep 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | Buy | 1,905,095 | 245.9400 | NSE |
| 7 Sep 2026 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Sell | 768,884 | 244.8000 | NSE |
| 7 Sep 2026 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Buy | 760,751 | 244.8600 | NSE |
| 7 Sep 2026 | HRTI PRIVATE LIMITED | Bulk | Buy | 629,067 | 242.9000 | NSE |
| 7 Sep 2026 | HRTI PRIVATE LIMITED | Bulk | Sell | 564,689 | 244.0600 | NSE |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from Hikal Chemical Industries Ltd. to Hikal Ltd. |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 6 Aug 2026 | Financial Results/Other business matters | Yes |
| 27 May 2026 | Financial Results/Dividend/Other business matters | Yes |
| 11 Feb 2026 | Financial Results/Dividend | Yes |
| 13 Nov 2025 | Financial Results | Yes |
| 6 Nov 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 1 Oct 2026 | Company Update | Hikal Ltd - 524735 - Announcement under Regulation 30 (LODR)-Resignation of Director |
| 1 Oct 2026 | Company Update | Hikal Ltd - 524735 - Announcement under Regulation 30 (LODR)-Change in Management |
| 1 Oct 2026 | Others | Hikal Ltd - 524735 - Board Meeting Outcome for Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Outcome Of Board Meeting |
| 29 Sep 2026 | Company Update | Hikal Ltd - 524735 - Disclosure Under Regulation 30 Of SEBI (LODR), 2015 - ESG Rating |
| 28 Sep 2026 | Insider Trading / SAST | Hikal Ltd - 524735 - Closure of Trading Window |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
